RÉSUMÉ DIGEST
ACT 301 (SB 148) 2024 Regular Session Mizell
Existing law provides certain requirements for implementation of step therapy or fail first
protocols used by any commercial health coverage plan.
Existing law requires health coverage plans that restrict medications through step therapy
or fail first protocol to have a process for the prescribing practitioner to request to override
the restriction if certain criteria are met.
New law authorizes a prescribing practitioner to request an override if the health coverage
plan's required prescription drug for postpartum depression under a step therapy or fail first
protocol is not indicated by the U.S. Food and Drug Administration for postpartum
depression on the prescription drug's approved labeling.
Effective August 1, 2024.
(Adds R.S. 22:1053(C)(6))